secwatch.observer — SEC 8-K summary
======================================

Issuer:     PULSE BIOSCIENCES, INC. (PLSE)
CIK:        0001625101
Form:       8-K
Filed at:   2023-12-22T23:59:59+00:00
Accession:  0001437749-23-035170
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Pulse Biosciences stockholders approve equity plan amendment and ratify executive option grants
--------------------------------------------------------------------------------

- Proposal 1 (increase share reserve by 1,375,000 shares) passed with 38.3M for, 2.97M against.
- Proposal 2 (ratify options for 1,505,000 shares at $4.38) passed with 39.2M for, 2.06M against.
- Ratified options include grants to CEO Kevin Danahy (460,000), Darrin Uecker (330,000), Mitchell Levinson (100,000).
- Options have 10-year term, vest at 6-year anniversary or 1-year after change in control.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625101/000143774923035170/0001437749-23-035170-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625101/000143774923035170/plse20231219_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-035170

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer